[1]
E. V. . Saenz, A. . Golibkhon, and Y. . Ibragim, “A Comprehensive Analysis of Visfatin Drug in Type 2 Diabetes, Insulin Resistance, and Cardiovascular Disease”, Journal of Prevention, Diagnosis and Management of Human Diseases, vol. 3, no. 04, pp. 9–17, Jun. 2023.